Lilly Licenses Stipple Epitope Discovery Programs

Stipple Bio disclosed a multi-target, multi-modality oncology research and license agreement with Lilly on November 16. Lilly receives exclusive worldwide product rights; Stipple receives an undisclosed upfront payment and equity investment and can earn…




